During the past decade, NANOGEN Pharmaceutical Biotechnology JSC conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "NANOGEN Pharmaceutical Biotechnology JSC" #1 collaborator was "Vietstar Biomedical Research" with 2 trials as a collaborator, "CLINICAL RESEARCH VIET NAM SKILL TRAINING AND CONSULTING COMPANY LIMITED" with 1 trials as a collaborator, "Clinical Research Consultants, Inc." with 1 trials as a collaborator, "Clinical Research Viet Nam Skill Training And Consultant Company Limited" with 1 trials as a collaborator and "MEDPHASE CLINICAL RESEARCH CONSULTANT COMPANY LIMITED" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "NANOGEN Pharmaceutical Biotechnology JSC" are "Anemia" (1 trials), "Chronic Kidney Disease" (1 trials) and "Chronic Kidney Disease Requiring Chronic Dialysis" (1 trials). Many other conditions were trialed in "NANOGEN Pharmaceutical Biotechnology JSC" in a lesser frequency.

Most popular intervention types in "NANOGEN Pharmaceutical Biotechnology JSC" are "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Stimus" (1 trials) and "Stimus (NNG-DEPO)" (1 trials). Other intervention names were less common.

The vast majority of trials in "NANOGEN Pharmaceutical Biotechnology JSC" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NANOGEN Pharmaceutical Biotechnology JSC". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NANOGEN Pharmaceutical Biotechnology JSC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in NANOGEN Pharmaceutical Biotechnology JSC, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".